Net Loss Per Share - Anti-dilutive Securities (Details) - shares	12 Months Ended
Dec. 31, 2025	Dec. 31, 2024
Options to purchase common stock
Net Loss Per Share
Anti-dilutive securities excluded from computation of diluted net (loss) per share	10,675,615	8,706,197
Unvested restricted stock units
Net Loss Per Share
Anti-dilutive securities excluded from computation of diluted net (loss) per share	599,675
Common stock to be issued to InnoCare
Net Loss Per Share
Anti-dilutive securities excluded from computation of diluted net (loss) per share	2,000,000

Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482662/260-10-50-1

Name:	us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration